Tamoxifen Combined with Hormone Replacement in Women with Thin Endometrium Receiving Frozen-Thawed Embryo Transfer for Promoting Endometrial Growth: A Double-Blinded, Randomized Controlled Trial
International Journal of General Medicine · 2026-05 · Volume 19 · 1-9
DOI: 10.2147/ijgm.s587828 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of General Medicine, 2026-05. Verfasst von Qingqing Shi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Reproductive Medicine and Obstetrics and Gynecology, Drum Tower Clinic Medical College of Nanjing Medical University, Nanjing, 210008, Peo…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
Thin endometrium continues to pose a significant challenge in assisted reproductive technology (ART) cycles, necessitating further exploration of therapeutic approaches. Tamoxifen (TMXF) has been primarily used in ovarian stimulation therapy and can also be implemented as an endometrial preparation protocol, potentially improving endometrial thickness. Does TMXF combined with hormone replacement therapy (HRT) in women with thin endometrium receiving frozen-thawed embryo transfer (FET) improve the endometrial thickness and pregnancy outcome compared to hormone replacement alone?
Methods
This single-centre prospective double-blind randomized controlled trial ran between March 2020 and October 2022. In it, 120 patients with thin endometrium were randomized to TMXF-HRT and control HRT groups at a 1:1 ratio. The primary outcome was endometrium thickness. The secondary outcomes include embryo implantation rate, miscarriage rate and live birth rate. This trial is registered at the ClinicalTrials.gov, number NCT04292886 (Registration Date: March 1, 2020).
Results
Endometrial thickness was significantly greater in the TMXF-HRT group than in the HRT alone group (7.80 ± 0.93 vs 6.93 ± 0.80 mm, P < 0.001), and multivariate analysis confirmed a positive effect of TMXF supplementation on endometrial thickness. However, no significant differences were observed between the two groups in embryo implantation rate or live birth rate.
Conclusion
TMXF combined with HRT can significantly increase endometrial thickness and has the potential to improve clinical pregnancy outcomes (the difference was not statistically significant).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Reproductive Medicine and Obstetrics and Gynecology, Drum Tower Clinic Medical College of Nanjing Medical University, Nanjing, 210008, People's Republic of China.
ORCID-Profile: Qingqing Shi, Na Kong, Chenyang Huang
Zitieren
APA
Shi, Q., Mei, J., Yan, G., Kong, N., Liu, J., Shen, X., Sun, Y., Lu, F., Jiang, Y., Sun, H., & Huang, C. (2026). Tamoxifen Combined with Hormone Replacement in Women with Thin Endometrium Receiving Frozen-Thawed Embryo Transfer for Promoting Endometrial Growth: A Double-Blinded, Randomized Controlled Trial. International Journal of General Medicine, Volume 19, 1-9. https://doi.org/10.2147/ijgm.s587828
Vancouver
Shi Q, Mei J, Yan G, Kong N, Liu J, Shen X, et al. Tamoxifen Combined with Hormone Replacement in Women with Thin Endometrium Receiving Frozen-Thawed Embryo Transfer for Promoting Endometrial Growth: A Double-Blinded, Randomized Controlled Trial. International Journal of General Medicine. 2026;Volume 19:1-9. doi:10.2147/ijgm.s587828
BibTeX
@article{Shi2026,
author = {Shi, Qingqing and Mei, Jie and Yan, Guijun and Kong, Na and Liu, Jingyu and Shen, Xiaoyue and Sun, Yanxin and Lu, Feifei and Jiang, Yue and Sun, Haixiang and Huang, Chenyang},
title = {Tamoxifen Combined with Hormone Replacement in Women with Thin Endometrium Receiving Frozen-Thawed Embryo Transfer for Promoting Endometrial Growth: A Double-Blinded, Randomized Controlled Trial},
journal = {International Journal of General Medicine},
year = {2026},
volume = {Volume 19},
pages = {1--9},
doi = {10.2147/ijgm.s587828}
}
EUVIMED